
The Role of Human AB Serum in Optimizing T & NK Cell Expansion in Cell Therapy
Adoptive cell therapy (ACT), including TILs, CAR T, NK, and CAR NK cell therapies, is revolutionizing immunotherapy. With over 2,000 clinical trials underway (ClinicalTrials.gov, 2025),